Multi-centre evaluation of pre-transfusional routine tests using 8-column format gel cards (DG Gel®)

No prior work had resolved the performance characteristics of the 8-column Grifols DG Gel system across diverse clinical settings. Current laboratory practices often rely on established gel cards or traditional tube techniques for pre-transfusional testing. Improving diagnostic efficiency and patient safety remains a primary goal for modern blood banks. That uncertainty drove researchers to investigate whether newer high-density formats could match existing standards. Prior research has shown that multi-center validation is necessary to ensure broad applicability of new diagnostic tools. Many laboratories seek cost-effective solutions that maintain high sensitivity and specificity for routine immunohematological analyses. This gap motivated a comprehensive assessment of the 8-column format in real-world environments. The study addresses the need for reliable data regarding the integration of these specific cards into existing workflows.

The study aimed to perform a multi-center evaluation of the 8-column Grifols DG Gel system to assess its suitability for daily laboratory routines. Researchers sought to determine if this platform could improve performance and cost-effectiveness in transfusion medicine. The investigation addressed the need for reliable data regarding the adaptability of this technology within United Kingdom clinical settings. By comparing the system against established reference methods, the team intended to validate its diagnostic accuracy for pre-transfusional testing. This work was motivated by the desire to enhance patient safety through more efficient immunohaematological laboratory practices. The researchers focused on measuring key performance indicators such as sensitivity, specificity, and predictive values. They also aimed to confirm the reliability of the system for diverse tasks including ABO/D grouping and antibody identification. Ultimately, the project sought to provide evidence-based support for the integration of this high-density format into routine clinical workflows.

The review approach involved a multi-center evaluation conducted across several clinical laboratories in the United Kingdom. Investigators processed 2255 patient specimens to generate a total of 4281 individual immunohematological analyses. Each case underwent parallel testing using the Grifols DG Gel system and the local reference method. Reference standards included either DiaMed-ID cards or traditional tube techniques depending on the specific laboratory site. The team performed ABO/D grouping, antibody screening, and Rh phenotyping alongside K antigen determination. They also included neonate testing consisting of ABO/D grouping and direct anti-globulin tests. This structured design ensured that the new technology could be assessed against established diagnostic benchmarks. The methodology focused on measuring concordance, sensitivity, specificity, and predictive values to determine overall system performance.

Key findings from the literature demonstrate that the 8-column system achieved 97.7% concordance with reference methods across all tests. ABO grouping results showed 99.95% sensitivity and 99.96% specificity, with a positive predictive value of 99.89%. For D grouping, the system reached 99.78% sensitivity and 100% specificity, with a positive predictive value of 100%. Antibody screening yielded 90.63% sensitivity and 99.94% specificity, while the negative predictive value was 99.15%. Rh subgroups and K antigen types showed 100% concordance between the tested systems. Antibody specificity detection accuracy reached 96.95% for the Grifols system, compared to 95.29% for the DiaMed-ID reference. Newborn testing resulted in 100% concordance for ABO/D grouping and 89.9% for direct anti-globulin tests. These values confirm the high diagnostic performance of the evaluated gel card format.

The authors propose that the 8-column gel system provides a reliable and safe platform for routine laboratory tasks. Their findings indicate that this technology performs effectively when compared to standard reference methods currently in use. The data suggest that high concordance rates support the adoption of this system for blood grouping and antibody screening. Researchers highlight the high sensitivity and specificity observed across most tested parameters. The study demonstrates that the system is well-suited for the demands of a busy transfusion environment. These results imply that laboratories can transition to this format without compromising diagnostic accuracy. The authors conclude that the system meets the requirements for modern immunohaematology practice. Future implementation may benefit from the observed performance metrics documented in this multi-center evaluation.